A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

In vivo 19F MRI for Cell Tracking

14.9K views

⸱

DOI:

10.3791/50802

⸱

November 25th, 2013

 ,  ,  ,  ,  ,  , 

In This Article

Summary

We describe a general protocol for in vivo cell tracking using MRI in a mouse model with ex vivo labeled cells. A typical protocol for cell labeling, image acquisition processing and quantification is included.

Abstract

In vivo 19F MRI allows quantitative cell tracking without the use of ionizing radiation. It is a noninvasive technique that can be applied to humans. Here, we describe a general protocol for cell labeling, imaging, and image processing. The technique is applicable to various cell types and animal models, although here we focus on a typical mouse model for tracking murine immune cells. The most important issues for cell labeling are described, as these are relevant to all models. Similarly, key imaging parameters are listed, although the details will vary depending on the MRI system and the individual setup. Finally, we include an image processing protocol for quantification. Variations for this, and other parts of the protocol, are assessed in the Discussion section. Based on the detailed procedure described here, the user will need to adapt the protocol for each specific cell type, cell label, animal model, and imaging setup. Note that the protocol can also be adapted for human use, as long as clinical restrictions are met.

Introduction

In vivo cell tracking is essential for the optimization and monitoring of cellular therapeutics1. Due to its noninvasive nature, imaging offers excellent opportunities to monitor cells in vivo. Magnetic Resonance Imaging (MRI) is independent of ionizing radiation and allows a superior imaging resolution and intrinsic soft tissue contrast. MRI-based cell tracking has already been used clinically to follow dendritic cells in melanoma patients2. Conventional clinical MRI is carried out on the 1H nucleus, present in mobile water in tissues. It is also possible to carry out MRI on other active nuclei, such as 13....

Access restricted. Please log in or start a trial to view this content.

Protocol

Note: All experiments and procedures involving animals must be carried out in accordance with relevant ethical guidelines and conform with standard animal care and humane requirements.

1. Cell Labeling (Standard Protocol with Coincubation)

  1. Add 19F label8 to immature DCs at a concentration of 4 mg/106 cells (in 2 ml medium). Swirl gently to mix.
  2. Incubate the cells with the label for 3 days before maturing and harvesting the DCs.
  3. Collect the DCs and remove excess label by washing at least 3x in PBS. Count the cells.
  4. Resuspend in a small volume of PBS for injection or f....

Access restricted. Please log in or start a trial to view this content.

Results

Here we show the typical results for a protocol involving the transfer of 19F-labeled cells homing to a draining lymph node. Figure 2 shows a 19F NMR spectrum of 106 labeled cells using a TFA reference. The imaging setup was carried out as described in the protocol (Figure 3). For the in vivo imaging, we used a reference consisting of a sealed cylinder of the same label used for the cells placed between the feet of the mouse. A representative pro.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The protocol outlined here describes the general procedure for in vivo 19F MRI cell tracking. Despite the described co-incubation method, there are several different protocols for labeling cells with a 19F agent. However, the co-incubation is most often used and can be further optimized e.g. by addition of transfection agents6. The actual cell labeling protocol will depend on the cell type. Only key labeling steps are described in the protocol here. Generally, the label .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have no conflicts of interests to disclose.

Acknowledgements

We would like to acknowledge Nadine Henn and Arend Heerschap for their valuable assistance. This work was supported by the Netherlands Institute of Regenerative Medicine (NIRM, FES0908), the EU FP7 program ENCITE (HEALTH-F5-2008-201842) and TargetBraIn (HEALTH-F2-2012-279017), a grant from the Volkswagen Foundation (I/83 443), the Netherlands Organization for Scientific Research (VENI 700.10.409 and Vidi 917.76.363), ERC (Advanced Grant 269019), and Radboud University Nijmegen Medical Centre (AGIKO-2008-2-4).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
REAGENTS
PBSSigma-AldrichMFCD00131855
TFASigma-Aldrich76-05-1
Ketamine (Ketavet)Pfizer778-551
Xylazine (Rompun)BayerQN05 cm92
Ophtosan Produlab Pharma2702eye ointment
Material name
MRI scannerBruker Biospec
NMR spectrometerBruker Biospec

References

  1. Srinivas, M., et al. Imaging of cellular therapies. Adv. Drug Deliv. Rev. 62, 1080-1093 (2010).
  2. de Vries, I. J., et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

19F MRIFluorine LabelingNMR SpectroscopyImage ProcessingProton MRIB1 MappingFlip Angle CorrectionCell QuantificationDendritic Cells